欢迎来到《四川大学学报(医学版)》
王保宁, 潘兴, 黄筱钧等. 重组幽门螺杆菌多表位疫苗工程菌株的构建及其微生物学特性研究[J]. 四川大学学报(医学版), 2015, 46(3): 354-358.
引用本文: 王保宁, 潘兴, 黄筱钧等. 重组幽门螺杆菌多表位疫苗工程菌株的构建及其微生物学特性研究[J]. 四川大学学报(医学版), 2015, 46(3): 354-358.
WANG Bao-ning, PAN Xing, HUANG Xiao-jun. et al. The New Bacteria Expressing Recombinant Multi-epitope Vaccine againstHelicobacter pylori and ItsMicrobiological Characteristics[J]. Journal of Sichuan University (Medical Sciences), 2015, 46(3): 354-358.
Citation: WANG Bao-ning, PAN Xing, HUANG Xiao-jun. et al. The New Bacteria Expressing Recombinant Multi-epitope Vaccine againstHelicobacter pylori and ItsMicrobiological Characteristics[J]. Journal of Sichuan University (Medical Sciences), 2015, 46(3): 354-358.

重组幽门螺杆菌多表位疫苗工程菌株的构建及其微生物学特性研究

The New Bacteria Expressing Recombinant Multi-epitope Vaccine againstHelicobacter pylori and ItsMicrobiological Characteristics

  • 摘要: 目的 构建含有幽门螺杆菌尿素酶(ureI、ureB)及霍乱毒素B亚单位(ctB)融合片段的多表位疫苗工程菌,并研究其微生物学特性。方法 通过生物信息学方法从ureI、ureB基因中筛选出T细胞和B细胞优势表位,通过柔性Linker相连,并在其N端加入分子内佐剂序列ctB,按照大肠杆菌BL21(DE3)的密码子偏好性进行密码子优化,即为BIB序列。人工合成之后,插入原核表达质粒pET28a(+)中,构建pET28a(+)/ctB-ureI-ureB〔pET28a(+)/BIB〕重组质粒。经限制性内切酶酶切鉴定及DNA测序鉴定正确后,将质粒转化入大肠杆菌BL21(DE3)中。BIB工程菌经乳糖诱导表达后,SDS-PAGE检测重组蛋白BIB的表达情况,并对其N端氨基酸序列和相对分子质量进行测定,Western blot对其进行抗原性鉴定。结果 原核表达质粒pET28a(+)/BIB经双酶切和测序鉴定构建正确,SDS-PAGE电泳显示在相对分子质量33×103处有一条明显条带,其N端氨基酸序列和相对分子质量与设计序列100%一致,Western blot结果显示BIB可以与抗幽门螺杆菌悉尼株(SS1株)小鼠血清及鼠抗CTB单抗产生特异性反应。结论 成功构建了幽门螺杆菌多表位重组原核表达工程菌,该工程菌表达的BIB蛋白抗原性良好。

     

    Abstract: Objective To construct the engineering bacteria with recombinant plasmid expressing the multi-epitope vaccine which composed of Helicobacter pylori urea membrane channel protein (UreI), Helicobacter pylori urease B subunit (UreB) and cholera toxin B subunit (CTB), and then to study it’s microbiological characteristics. Methods The sequence contains some dominant epitopes of Helicobacter pylori UreI and UreB was designed, and ctB was added at the N-terminal, all the sequence were linked by flexible linkers. Codon optimization was done according to Escherichia coli (E.coli) BL21 (DE3) bias, the optimized sequence was designated BIB. BIB sequence was synthesized and cloned into plasmid pET28a(+). The recombinant plasmid was confirmed by restriction enzyme digestion and DNA sequencing. The recombinant protein BIB was expressed in E.coli BL21 (DE3) and analyzed by Western blot. Results The plasmid of pET28a(+)/BIB was constructed successfully, confirmed by restriction enzyme digestion and DNA sequencing. The recombinant protein BIB with relative molecular mass about 33×103 could be produced by E.coli BL21 (DE3) and was detected by Western blot. The relative molecular mass and N-terminal amino acid sequence of BIB were 100% identity with the design. Conclution The engineering bacteria with recombinant plasmid expressing the multi-epitope vaccine against Helicobacter pylori was constructed successfully. The recombinant protein BIB can be identified by anti-Sydney strain 1 of Helicobacter pylori (H. pylori SS1) polyclonal antibody and anti-CTB monoclonal antibody, which demonstrated that BIB has the expected antigenicity.

     

© 2015 《四川大学学报(医学版)》编辑部 版权所有 cc

开放获取 本文遵循知识共享署名—非商业性使用4.0国际许可协议(CC BY-NC 4.0),允许第三方对本刊发表的论文自由共享(即在任何媒介以任何形式复制、发行原文)、演绎(即修改、转换或以原文为基础进行创作),必须给出适当的署名,提供指向本文许可协议的链接,同时标明是否对原文作了修改;不得将本文用于商业目的。CC BY-NC 4.0许可协议详情请访问 https://creativecommons.org/licenses/by-nc/4.0

/

返回文章
返回